Which of the following best explains how a mouse is able to navigate its environment to find food?

1. Venter J. C., Adams M. D., Myers E. W., Li P. W., Mural R. J., Sutton G. G., Smith H. O., Yandell M., Evans C. A., Holt R. A., et al. The sequence of the human genome. Science. 2001;291:1304–1351. [PubMed] [Google Scholar]

2. Lander E. S., Linton L. M., Birren B., Nusbaum C., Zody M. C., Baldwin J., Devon K., Dewar K., Doyle M., FitzHugh W., et al. Initial sequencing and analysis of the human genome. Nature (London) 2001;409:860–921. [PubMed] [Google Scholar]

3. Brudno M., Poliakov A., Salamov A., Cooper G. M., Sidow A., Rubin E. M., Solovyev V., Batzoglou S., Dubchak I. Automated whole-genome multiple alignment of rat, mouse, and human. Genome Res. 2004;14:685–692. [PMC free article] [PubMed] [Google Scholar]

4. Tecott L. H. The genes and brains of mice and men. Am. J. Psychiatry. 2003;160:646–656. [PubMed] [Google Scholar]

5. Rhodes J. S., Garland T. Differential sensitivity to acute administration of Ritalin, apomorphine, SCH 23390, but not raclopride in mice selectively bred for hyperactive wheel-running behavior. Psychopharmacology (Berlin) 2003;167:242–250. [PubMed] [Google Scholar]

6. Farooqi I. S., O'Rahilly S. Monogenic human obesity syndromes. Recent Prog. Horm. Res. 2004;59:409–424. [PubMed] [Google Scholar]

7. Gardian G., Vecsei L. Huntington's disease: pathomechanism and therapeutic perspectives. J. Neural Transm. 2004;111:1485–1494. [PubMed] [Google Scholar]

8. Phillips T. J., Belknap J. K. Complex-trait genetics: emergence of multivariate strategies. Nat. Rev. Neurosci. 2002;3:478–485. [PubMed] [Google Scholar]

9. Crabbe J. C. Quantitative trait locus gene mapping: a new method for locating alcohol response genes. Addict Biol. 1996;1:229–235. [PubMed] [Google Scholar]

10. Johnson A. B. Alexander disease: a leukodystrophy caused by a mutation in GFAP. Neurochem. Res. 2004;29:961–964. [PubMed] [Google Scholar]

11. Parkinson N. J., Olsson C. L., Hallows J. L., McKee-Johnson J., Keogh B. P., Noben-Trauth K., Kujawa S. G., Tempel B. L. Mutant beta-spectrin 4 causes auditory and motor neuropathies in quivering mice. Nat. Genet. 2001;29:61–65. [PubMed] [Google Scholar]

12. Boillee S., Peschanski M., Junier M. P. The wobbler mouse: a neurodegeneration jigsaw puzzle. Mol. Neurobiol. 2003;28:65–106. [PubMed] [Google Scholar]

13. Herron B. J., Bryda E. C., Heverly S. A., Collins D. N., Flaherty L. Scraggly, a new hair loss mutation on mouse chromosome 19. Mamm. Genome. 1999;10:864–869. [PubMed] [Google Scholar]

14. Russell W. L., Kelly E. M., Hunsicker P. R., Bangham J. W., Maddux S. C., Phipps E. L. Specific-locus test shows ethylnitrosourea to be the most potent mutagen in the mouse. Proc. Natl. Acad. Sci. U.S.A. 1979;76:5818–5819. [PMC free article] [PubMed] [Google Scholar]

15. Balling R. ENU mutagenesis: analyzing gene function in mice. Annu. Rev. Genomics Hum. Genet. 2001;2:463–492. [PubMed] [Google Scholar]

16. Meyer C. W., Korthaus D., Jagla W., Cornali E., Grosse J., Fuchs H., Klingenspor M., Roemheld S., Tschop M., Heldmaier G., et al. A novel missense mutation in the mouse growth hormone gene causes semidominant dwarfism, hyperghrelinemia, and obesity. Endocrinology. 2004;145:2531–2541. [PubMed] [Google Scholar]

17. Hrabe de Angelis M., Balling R. Large scale ENU screens in the mouse: genetics meets genomics. Mutat. Res. 1998;400:25–32. [PubMed] [Google Scholar]

18. Brown S. D., Balling R. Systematic approaches to mouse mutagenesis. Curr. Opin. Genet. Dev. 2001;11:268–273. [PubMed] [Google Scholar]

19. Tosal L., Comendador M. A., Sierra L. M. In vivo repair of ENU-induced oxygen alkylation damage by the nucleotide excision repair mechanism in Drosophila melanogaster. Mol. Genet. Genomics. 2001;265:327–335. [PubMed] [Google Scholar]

20. Graw J., Pretsch W., Loster J. Mutation in intron 6 of the hamster Mitf gene leads to skipping of the subsequent exon and creates a novel animal model for the human Waardenburg syndrome type II. Genetics. 2003;164:1035–1041. [PMC free article] [PubMed] [Google Scholar]

21. De Stasio E., Lephoto C., Azuma L., Holst C., Stanislaus D., Uttam J. Characterization of revertants of unc-93(e1500) in Caenorhabditis elegans induced by N-ethyl-N-nitrosourea. Genetics. 1997;147:597–608. [PMC free article] [PubMed] [Google Scholar]

22. Voss A. K., Thomas T., Gruss P. Efficiency assessment of the gene trap approach. Dev. Dyn. 1998;212:171–180. [PubMed] [Google Scholar]

23. Durick K., Mendlein J., Xanthopoulos K. G. Hunting with traps: genomewide strategies for gene discovery and functional analysis. Genome Res. 1999;9:1019–1025. [PubMed] [Google Scholar]

24. Torres M., Stoykova A., Huber O., Chowdhury K., Bonaldo P., Mansouri A., Butz S., Kemler R., Gruss P. An alpha-E-catenin gene trap mutation defines its function in preimplantation development. Proc. Natl. Acad. Sci. U.S.A. 1997;94:901–906. [PMC free article] [PubMed] [Google Scholar]

25. Stewart C. L., Ruther U., Garber C., Vanek M., Wagner E. F. The expression of retroviral vectors in murine stem cells and transgenic mice. J. Embryol. Exp. Morphol. 1986;97:263–275. [PubMed] [Google Scholar]

26. Muller U. Ten years of gene targeting: targeted mouse mutants, from vector design to phenotype analysis. Mech. Dev. 1999;82:3–21. [PubMed] [Google Scholar]

27. Aszodi A., Hunziker E. B., Olsen B. R., Fassler R. The role of collagen II and cartilage fibril-associated molecules in skeletal development. Osteoarthritis Cartilage. 2001;9(suppl. A):S150–S159. [PubMed] [Google Scholar]

28. Lewandoski M. Conditional control of gene expression in the mouse. Nat. Rev. Genet. 2001;2:743–755. [PubMed] [Google Scholar]

29. Schneider A., Guan Y., Zhang Y., Magnuson M. A., Pettepher C., Loftin C. D., Langenbach R., Breyer R. M., Breyer M. D. Generation of a conditional allele of the mouse prostaglandin EP4 receptor. Genesis. 2004;40:7–14. [PubMed] [Google Scholar]

30. Araki K., Araki M., Yamamura K. Targeted integration of DNA using mutant lox sites in embryonic stem cells. Nucleic Acids Res. 1997;25:868–872. [PMC free article] [PubMed] [Google Scholar]

31. Gu H., Marth J. D., Orban P. C., Mossmann H., Rajewsky K. Deletion of a DNA polymerase beta gene segment in T cells using cell type-specific gene targeting. Science. 1994;265:103–106. [PubMed] [Google Scholar]

32. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 1995;269:1427–1429. [PubMed] [Google Scholar]

33. Mansuy I. M., Bujard H. Tetracycline-regulated gene expression in the brain. Curr. Opin. Neurobiol. 2000;10:593–596. [PubMed] [Google Scholar]

34. Yamamoto A., Lucas J. J., Hen R. Reversal of neuropathology and motor dysfunction in a conditional model of Huntington's disease. Cell. 2000;101:57–66. [PubMed] [Google Scholar]

35. Ravikumar B., Vacher C., Berger Z., Davies J. E., Luo S., Oroz L. G., Scaravilli F., Easton D. F., Duden R., O'Kane C. J., Rubinsztein D. C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004;36:585–595. [PubMed] [Google Scholar]

36. Letts V. A., Valenzuela A., Kirley J. P., Sweet H. O., Davisson M. T., Frankel W. N. Genetic and physical maps of the stargazer locus on mouse chromosome 15. Genomics. 1997;43:62–68. [PubMed] [Google Scholar]

37. Parmigiani S., Palanza P., Rogers J., Ferrari P. F. Selection, evolution of behavior and animal models in behavioral neuroscience. Neurosci. Biobehav. Rev. 1999;23:957–969. [PubMed] [Google Scholar]

38. Owen E. H., Logue S. F., Rasmussen D. L., Wehner J. M. Assessment of learning by the Morris water task and fear conditioning in inbred mouse strains and F1 hybrids: implications of genetic background for single gene mutations and quantitative trait loci analyses. Neuroscience. 1997;80:1087–1099. [PubMed] [Google Scholar]

39. Crawley J. N., Belknap J. K., Collins A., Crabbe J. C., Frankel W., Henderson N., Hitzemann R. J., Maxson S. C., Miner L. L., Silva A. J., et al. Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies. Psychopharmacology (Berlin) 1997;132:107–124. [PubMed] [Google Scholar]

40. Fox W. M. Reflex-ontogeny and behavioural development of the mouse. Anim. Behav. 1965;13:234–241. [PubMed] [Google Scholar]

41. Hill J. M., Gozes I., Hill J. L., Fridkin M., Brenneman D. E. Vasoactive intestinal peptide antagonist retards the development of neonatal behaviors in the rat. Peptides. 1991;12:187–192. [PubMed] [Google Scholar]

42. Hill J. M., Mervis R. F., Avidor R., Moody T. W., Brenneman D. E. HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates. Brain Res. 1993;603:222–233. [PubMed] [Google Scholar]

43. Wu J. Y., Henins K. A., Gressens P., Gozes I., Fridkin M., Brenneman D. E., Hill J. M. Neurobehavioral development of neonatal mice following blockade of VIP during the early embryonic period. Peptides. 1997;18:1131–1137. [PubMed] [Google Scholar]

44. Crawley J. N., Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Horm. Behav. 1997;31:197–211. [PubMed] [Google Scholar]

45. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1968;13:222–257. [PubMed] [Google Scholar]

46. Moser V. C., Cheek B. M., MacPhail R. C. A multidisciplinary approach to toxicological screening: III. Neurobehavioral toxicity. J. Toxicol. Environ. Health. 1995;45:173–210. [PubMed] [Google Scholar]

47. Rogers D. C., Fisher E. M., Brown S. D., Peters J., Hunter A. J., Martin J. E. Behavioral and functional analysis of mouse phenotype: SHIRPA, a proposed protocol for comprehensive phenotype assessment. Mamm. Genome. 1997;8:711–713. [PubMed] [Google Scholar]

48. Paylor R., Nguyen M., Crawley J. N., Patrick J., Beaudet A., Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn. Mem. 1998;5:302–316. [PMC free article] [PubMed] [Google Scholar]

49. Koehl M., Battle S. E., Turek F. W. Sleep in female mice: a strain comparison across the estrous cycle. Sleep. 2003;26:267–272. [PubMed] [Google Scholar]

50. Nordstrom E. J., Burton F. H. A transgenic model of comorbid Tourette's syndrome and obsessive-compulsive disorder circuitry. Mol. Psychiatry. 2002;7:617–625. [PubMed] [Google Scholar]

51. Finn D. A., Sinnott R. S., Ford M. M., Long S. L., Tanchuck M. A., Phillips T. J. Sex differences in the effect of ethanol injection and consumption on brain allopregnanolone levels in C57BL/6 mice. Neuroscience. 2004;123:813–819. [PubMed] [Google Scholar]

52. Gao J., Cheon K., Nusinowitz S., Liu Q., Bei D., Atkins K., Azimi A., Daiger S. P., Farber D. B., Heckenlively J. R., et al. Progressive photoreceptor degeneration, outer segment dysplasia, and rhodopsin mislocalization in mice with targeted disruption of the retinitis pigmentosa-1 (Rp1) gene. Proc. Natl. Acad. Sci. U.S.A. 2002;99:5698–5703. [PMC free article] [PubMed] [Google Scholar]

53. Raber J., Wong D., Buttini M., Orth M., Bellosta S., Pitas R. E., Mahley R. W., Mucke L. Isoform-specific effects of human apolipoprotein E on brain function revealed in ApoE knockout mice: increased susceptibility of females. Proc. Natl. Acad. Sci. U.S.A. 1998;95:10914–10919. [PMC free article] [PubMed] [Google Scholar]

54. Raber J., Wong D., Yu G. Q., Buttini M., Mahley R. W., Pitas R. E., Mucke L. Apolipoprotein E and cognitive performance. Nature (London) 2000;404:352–354. [PubMed] [Google Scholar]

55. Henry K. R. Males lose hearing earlier in mouse models of late-onset age-related hearing loss; females lose hearing earlier in mouse models of early-onset hearing loss. Hear Res. 2004;190:141–148. [PubMed] [Google Scholar]

56. Gimenez E., Montoliu L. A simple polymerase chain reaction assay for genotyping the retinal degeneration mutation (Pdeb(rd1)) in FVB/N-derived transgenic mice. Lab. Anim. 2001;35:153–156. [PubMed] [Google Scholar]

57. Brown R. E., Stanford L., Schellinck H. M. Developing standardized behavioral tests for knockout and mutant mice. ILAR J. 2000;41:163–174. [PubMed] [Google Scholar]

58. Laviola G., Alleva E. Sibling effects on the behavior of infant mouse litters (Mus domesticus) J. Comp. Psychol. 1995;109:68–75. [PubMed] [Google Scholar]

59. vom Saal F. S., Grant W. M., McMullen C. W., Laves K. S. High fetal estrogen concentrations: correlation with increased adult sexual activity and decreased aggression in male mice. Science. 1983;220:1306–1309. [PubMed] [Google Scholar]

60. vom Saal F. S., Bronson F. H. In utero proximity of female mouse fetuses to males: effect on reproductive performance during later life. Biol. Reprod. 1978;19:842–853. [PubMed] [Google Scholar]

61. Svare B., Kinsley C. H., Mann M. A., Broida J. Infanticide: accounting for genetic variation in mice. Physiol. Behav. 1984;33:137–152. [PubMed] [Google Scholar]

62. Wainwright P. E., Gardner D., Pelkman C., McCutcheon D., Young C. Effects of early rearing experience on feeding behavior in B6D2F2 mice. Physiol. Behav. 1989;45:1189–1195. [PubMed] [Google Scholar]

63. Gervais M. C., DeFries J. C., Kuse A. R. Open-field behavior in mice: effect of litter size. Behav. Biol. 1977;20:519–522. [PubMed] [Google Scholar]

64. LaBarba R. C., White J. L. Litter size variations and emotional reactivity in BALB-c mice. J. Comp. Physiol. Psychol. 1971;75:254–257. [PubMed] [Google Scholar]

65. Kikusui T., Takeuchi Y., Mori Y. Early weaning induces anxiety and aggression in adult mice. Physiol. Behav. 2004;81:37–42. [PubMed] [Google Scholar]

66. Winslow J. T., Hearn E. F., Ferguson J., Young L. J., Matzuk M. M., Insel T. R. Infant vocalization, adult aggression, and fear behavior of an oxytocin null mutant mouse. Horm. Behav. 2000;37:145–155. [PubMed] [Google Scholar]

67. Reeb-Whitaker C. K., Paigen B., Beamer W. G., Bronson R. T., Churchill G. A., Schweitzer I. B., Myers D. D. The impact of reduced frequency of cage changes on the health of mice housed in ventilated cages. Lab. Anim. 2001;35:58–73. [PubMed] [Google Scholar]

68. Bronson F. H. The reproductive ecology of the house mouse. Q Rev. Biol. 1979;54:265–299. [PubMed] [Google Scholar]

69. Tsai P. P., Oppermann D., Stelzer H. D., Mahler M., Hackbarth H. The effects of different rack systems on the breeding performance of DBA/2 mice. Lab. Anim. 2003;37:44–53. [PubMed] [Google Scholar]

70. Dallman M. F., Akana S. F., Bell M. E., Bhatnagar S., Choi S., Chu A., Gomez F., Laugero K., Soriano L., Viau V. Warning! Nearby construction can profoundly affect your experiments. Endocrine. 1999;11:111–113. [PubMed] [Google Scholar]

71. Milligan S. R., Sales G. D., Khirnykh K. Sound levels in rooms housing laboratory animals: an uncontrolled daily variable. Physiol. Behav. 1993;53:1067–1076. [PubMed] [Google Scholar]

72. Ohlemiller K. K., Wright J. S., Dugan L. L. Early elevation of cochlear reactive oxygen species following noise exposure. Audiol. Neurootol. 1999;4:229–236. [PubMed] [Google Scholar]

73. Pfaff J., Stecker M. Loudness level and frequency content of noise in the animal house. Lab. Anim. 1976;10:111–117. [PubMed] [Google Scholar]

74. Quintero J. E., Kuhlman S. J., McMahon D. G. The biological clock nucleus: a multiphasic oscillator network regulated by light. J. Neurosci. 2003;23:8070–8076. [PMC free article] [PubMed] [Google Scholar]

75. Landi M. S., Kreider J. W., Lang C. M., Bullock L. P. Effects of shipping on the immune function in mice. Am. J. Vet. Res. 1982;43:1654–1657. [PubMed] [Google Scholar]

76. Tuli J. S., Smith J. A., Morton D. B. Stress measurements in mice after transportation. Lab. Anim. 1995;29:132–138. [PubMed] [Google Scholar]

77. Surwit R. S., Wang S., Petro A. E., Sanchis D., Raimbault S., Ricquier D., Collins S. Diet-induced changes in uncoupling proteins in obesity-prone and obesity-resistant strains of mice. Proc. Natl. Acad. Sci. U.S.A. 1998;95:4061–4065. [PMC free article] [PubMed] [Google Scholar]

78. Dess N. K., Choe S., Minor T. R. The interaction of diet and stress in rats: high-energy food and sucrose treatment. J. Exp. Psychol. Anim. Behav. Process. 1998;24:60–71. [PubMed] [Google Scholar]

79. Li D., Graef G. L., Yee J. A., Yan L. Dietary supplementation with high-selenium soy protein reduces pulmonary metastasis of melanoma cells in mice. J. Nutr. 2004;134:1536–1540. [PubMed] [Google Scholar]

80. Ravinet Trillou C., Arnone M., Delgorge C., Gonalons N., Keane P., Maffrand J. P., Soubrie P. Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice. Am. J. Physiol. 2003;284:R345–R353. [PubMed] [Google Scholar]

81. Collins S., Martin T. L., Surwit R. S., Robidoux J. Genetic vulnerability to diet-induced obesity in the C57BL/6J mouse: physiological and molecular characteristics. Physiol. Behav. 2004;81:243–248. [PubMed] [Google Scholar]

82. Thiele T. E., Naveilhan P., Ernfors P. Assessment of ethanol consumption and water drinking by NPY Y(2) receptor knockout mice. Peptides. 2004;25:975–983. [PubMed] [Google Scholar]

83. McQuade J. A., Xu M., Woods S. C., Seeley R. J., Benoit S. C. Ethanol consumption in mice with a targeted disruption of the dopamine-3 receptor gene. Addict Biol. 2003;8:295–303. [PubMed] [Google Scholar]

84. al Qatari M., Shih M. F., Taberner P. V. Chronic ethanol consumption ameliorates the maturity-onset diabetes-obesity syndrome in CBA mice. Alcohol Alcohol. 1996;31:89–99. [PubMed] [Google Scholar]

85. Belknap J. K., Richards S. P., O'Toole L. A., Helms M. L., Phillips T. J. Short-term selective breeding as a tool for QTL mapping: ethanol preference drinking in mice. Behav. Genet. 1997;27:55–66. [PubMed] [Google Scholar]

86. Belknap J. K., Crabbe J. C., Laursen S. E. Ethanol and diazepam withdrawal convulsions are extensively codetermined in WSP and WSR mice. Life Sci. 1989;44:2075–2080. [PubMed] [Google Scholar]

87. Crabbe J. C., Wahlsten D., Dudek B. C. Genetics of mouse behavior: interactions with laboratory environment. Science. 1999;284:1670–1672. [PubMed] [Google Scholar]

88. Wahlsten D., Metten P., Phillips T. J., Boehm S. L., II, Burkhart-Kasch S., Dorow J., Doerksen S., Downing C., Fogarty J., Rodd-Henricks K., et al. Different data from different labs: lessons from studies of gene-environment interaction. J. Neurobiol. 2003;54:283–311. [PubMed] [Google Scholar]

89. Bruserud O., Frostad S., Foss B. In vitro culture of acute myelogenous leukemia blasts: a comparison of four different culture media. J. Hematother. 1999;8:63–73. [PubMed] [Google Scholar]

90. Chabbert E., Lachaud L., Crobu L., Bastien P. Comparison of two widely used PCR primer systems for detection of toxoplasma in amniotic fluid, blood, and tissues. J. Clin. Microbiol. 2004;42:1719–1722. [PMC free article] [PubMed] [Google Scholar]

91. Roep B. O., Atkinson M. A., van Endert P. M., Gottlieb P. A., Wilson S. B., Sachs J. A. Autoreactive T cell responses in insulin-dependent (Type 1) diabetes mellitus. Report of the first international workshop for standardization of T cell assays. J. Autoimmun. 1999;13:267–282. [PubMed] [Google Scholar]

92. Brown R. E., Stevens D. R., Haas H. L. The physiology of brain histamine. Prog. Neurobiol. 2001;63:637–672. [PubMed] [Google Scholar]

93. Le Coniat M., Traiffort E., Ruat M., Arrang J. M., Berger R. Chromosomal localization of the human histamine H1-receptor gene. Hum. Genet. 1994;94:186–188. [PubMed] [Google Scholar]

94. Li H., Burkhardt C., Heinrich U. R., Brausch I., Xia N., Forstermann U. Histamine upregulates gene expression of endothelial nitric oxide synthase in human vascular endothelial cells. Circulation. 2003;107:2348–2354. [PubMed] [Google Scholar]

95. Izumi H., Makino Y., Shirakawa K., Garfield R. E. Role of nitric oxide on vasorelaxation in human umbilical artery. Am. J. Obstet. Gynecol. 1995;172:1477–1484. [PubMed] [Google Scholar]

96. Garbarg M., Schwartz J. C. Histamine receptors in the brain. N. Engl. Reg. Allergy Proc. 1985;6:195–200. [PubMed] [Google Scholar]

97. Arrang J. M., Garbarg M., Schwartz J. C. Auto-inhibition of brain histamine release mediated by a novel class (H3) of histamine receptor. Nature (London) 1983;302:832–837. [PubMed] [Google Scholar]

98. Lovenberg T. W., Roland B. L., Wilson S. J., Jiang X., Pyati J., Huvar A., Jackson M. R., Erlander M. G. Cloning and functional expression of the human histamine H3 receptor. Mol. Pharmacol. 1999;55:1101–1107. [PubMed] [Google Scholar]

99. Bockaert J., Pin J. P. Molecular tinkering of G protein-coupled receptors: an evolutionary success. EMBO J. 1999;18:1723–1729. [PMC free article] [PubMed] [Google Scholar]

100. Leurs R., Hoffmann M., Wieland K., Timmerman H. H3 receptor gene is cloned at last. Trends Pharmacol. Sci. 2000;21:11–12. [PubMed] [Google Scholar]

101. Uveges A. J., Kowal D., Zhang Y., Spangler T. B., Dunlop J., Semus S., Jones P. G. The role of transmembrane helix 5 in agonist binding to the human H3 receptor. J. Pharmacol. Exp. Ther. 2002;301:451–458. [PubMed] [Google Scholar]

102. Hancock A. A., Esbenshade T. A., Krueger K. M., Yao B. B. Genetic and pharmacological aspects of histamine H3 receptor heterogeneity. Life Sci. 2003;73:3043–3072. [PubMed] [Google Scholar]

103. Maggio R., Barbier P., Colelli A., Salvadori F., Demontis G., Corsini G. U. G protein-linked receptors: pharmacological evidence for the formation of heterodimers. J. Pharmacol. Exp. Ther. 1999;291:251–257. [PubMed] [Google Scholar]

104. Drutel G., Peitsaro N., Karlstedt K., Wieland K., Smit M. J., Timmerman H., Panula P., Leurs R. Identification of rat H3 receptor isoforms with different brain expression and signaling properties. Mol. Pharmacol. 2001;59:1–8. [PubMed] [Google Scholar]

105. Rouleau A., Heron A., Cochois V., Pillot C., Schwartz J. C., Arrang J. M. Cloning and expression of the mouse histamine H3 receptor: evidence for multiple isoforms. J. Neurochem. 2004;90:1331–1338. [PubMed] [Google Scholar]

106. Wieland K., Bongers G., Yamamoto Y., Hashimoto T., Yamatodani A., Menge W. M., Timmerman H., Lovenberg T. W., Leurs R. Constitutive activity of histamine H3 receptors stably expressed in SK-N-MC cells: display of agonism and inverse agonism by H3 antagonists. J. Pharmacol. Exp. Ther. 2001;299:908–914. [PubMed] [Google Scholar]

107. Clark E. A., Hill S. J. Sensitivity of histamine H3 receptor agonist-stimulated [35S]GTP gamma[S] binding to pertussis toxin. Eur. J. Pharmacol. 1996;296:223–225. [PubMed] [Google Scholar]

108. Schlicker E., Fink K., Detzner M., Gothert M. Histamine inhibits dopamine release in the mouse striatum via presynaptic H3 receptors. J. Neural Transm. Gen. Sect. 1993;93:1–10. [PubMed] [Google Scholar]

109. Schlicker E., Betz R., Gothert M. Histamine H3 receptor-mediated inhibition of serotonin release in the rat brain cortex. Naunyn Schmiedebergs Arch. Pharmacol. 1988;337:588–590. [PubMed] [Google Scholar]

110. Schlicker E., Schunack W., Gothert M. Histamine H3 receptor-mediated inhibition of noradrenaline release in pig retina discs. Naunyn Schmiedebergs Arch. Pharmacol. 1990;342:497–501. [PubMed] [Google Scholar]

111. Garcia M., Floran B., Arias-Montano J. A., Young J. M., Aceves J. Histamine H3 receptor activation selectively inhibits dopamine D1 receptor-dependent [3H]GABA release from depolarization-stimulated slices of rat substantia nigra pars reticulata. Neuroscience. 1997;80:241–249. [PubMed] [Google Scholar]

112. Silver R. B., Mackins C. J., Smith N. C., Koritchneva I. L., Lefkowitz K., Lovenberg T. W., Levi R. Coupling of histamine H3 receptors to neuronal Na+/H+ exchange: a novel protective mechanism in myocardial ischemia. Proc. Natl. Acad. Sci. U.S.A. 2001;98:2855–2859. [PMC free article] [PubMed] [Google Scholar]

113. Hill S. J., Ganellin C. R., Timmerman H., Schwartz J. C., Shankley N. P., Young J. M., Schunack W., Levi R., Haas H. L. International Union of Pharmacology. XIII. Classification of histamine receptors. Pharmacol. Rev. 1997;49:253–278. [PubMed] [Google Scholar]

114. Alguacil L. F., Perez-Garcia C. Histamine H3 receptor: a potential drug target for the treatment of central nervous system disorders. Curr. Drug Targets CNS Neurol. Disord. 2003;2:303–313. [PubMed] [Google Scholar]

115. Saper C. B., German D. C. Hypothalamic pathology in Alzheimer's disease. Neurosci. Lett. 1987;74:364–370. [PubMed] [Google Scholar]

116. Simpson J., Yates C. M., Watts A. G., Fink G. Congo red birefringent structures in the hypothalamus in senile dementia of the Alzheimer type. Neuropathol. Appl. Neurobiol. 1988;14:381–393. [PubMed] [Google Scholar]

117. Airaksinen M. S., Reinikainen K., Riekkinen P., Panula P. Neurofibrillary tangles and histamine-containing neurons in Alzheimer hypothalamus. Agents Actions. 1991;33:104–107. [PubMed] [Google Scholar]

118. Mazurkiewicz-Kwilecki I. M., Nsonwah S. Changes in the regional brain histamine and histidine levels in postmortem brains of Alzheimer patients. Can. J. Physiol. Pharmacol. 1989;67:75–78. [PubMed] [Google Scholar]

119. Panula P., Rinne J., Kuokkanen K., Eriksson K. S., Sallmen T., Kalimo H., Relja M. Neuronal histamine deficit in Alzheimer's disease. Neuroscience. 1998;82:993–997. [PubMed] [Google Scholar]

120. Cacabelos R., Yamatodani A., Niigawa H., Hariguchi S., Tada K., Nishimura T., Wada H., Brandeis L., Pearson J. Brain histamine in Alzheimer's disease. Methods Find. Exp. Clin. Pharmacol. 1989;11:353–360. [PubMed] [Google Scholar]

121. Perez-Garcia C., Morales L., Cano M. V., Sancho I., Alguacil L. F. Effects of histamine H3 receptor ligands in experimental models of anxiety and depression. Psychopharmacology (Berlin) 1999;142:215–220. [PubMed] [Google Scholar]

122. Nakamura T., Itadani H., Hidaka Y., Ohta M., Tanaka K. Molecular cloning and characterization of a new human histamine receptor, HH4R. Biochem. Biophys. Res. Commun. 2000;279:615–620. [PubMed] [Google Scholar]

123. Coge F., Guenin S. P., Rique H., Boutin J. A., Galizzi J. P. Structure and expression of the human histamine H4-receptor gene. Biochem. Biophys. Res. Commun. 2001;284:301–309. [PubMed] [Google Scholar]

124. Liu C., Wilson S. J., Kuei C., Lovenberg T. W. Comparison of human, mouse, rat, and guinea pig histamine H4 receptors reveals substantial pharmacological species variation. J. Pharmacol. Exp. Ther. 2001;299:121–130. [PubMed] [Google Scholar]

125. O'Reilly M., Alpert R., Jenkinson S., Gladue R. P., Foo S., Trim S., Peter B., Trevethick M., Fidock M. Identification of a histamine H4 receptor on human eosinophils – role in eosinophil chemotaxis. J. Recept. Signal Transduct. Res. 2002;22:431–448. [PubMed] [Google Scholar]

126. Hofstra C. L., Desai P. J., Thurmond R. L., Fung-Leung W. P. Histamine H4 receptor mediates chemotaxis and calcium mobilization of mast cells. J. Pharmacol. Exp. Ther. 2003;305:1212–1221. [PubMed] [Google Scholar]

126a. Charrey D. S. Neuroanatonical circuits modulating fear and anxiety. Acta Psychiatr. Scand., Suppl. 2003;417:38–50. [PubMed] [Google Scholar]

127. Wilson R. C., Vacek T., Lanier D. L., Dewsbury D. A. Open-field behavior in muroid rodents. Behav. Biol. 1976;17:495–506. [PubMed] [Google Scholar]

128. Tremml P., Lipp H. P., Muller U., Ricceri L., Wolfer D. P. Neurobehavioral development, adult openfield exploration and swimming navigation learning in mice with a modified beta-amyloid precursor protein gene. Behav. Brain Res. 1998;95:65–76. [PubMed] [Google Scholar]

129. Meyer L., Caston J. Stress alters caffeine action on investigatory behaviour and behavioural inhibition in the mouse. Behav. Brain Res. 2004;149:87–93. [PubMed] [Google Scholar]

130. Lister R. G. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology (Berlin) 1987;92:180–185. [PubMed] [Google Scholar]

131. Mulder G. B., Pritchett K. The elevated plus-maze. Contemp. Top. Lab. Anim. Sci. 2004;43:39–40. [PubMed] [Google Scholar]

132. Imaizumi M., Onodera K. The behavioral and biochemical effects of thioperamide, a histamine H3-receptor antagonist, in a light/dark test measuring anxiety in mice. Life Sci. 1993;53:1675–1683. [PubMed] [Google Scholar]

133. Imaizumi M., Miyazaki S., Onodera K. Effects of betahistine, a histamine H1 agonist and H3 antagonist, in a light/dark test in mice. Methods Find. Exp. Clin. Pharmacol. 1996;18:19–24. [PubMed] [Google Scholar]

134. Yuzurihara M., Ikarashi Y., Ishige A., Sasaki H., Maruyama Y. Anxiolytic-like effect of saiboku-to, an oriental herbal medicine, on histaminergics-induced anxiety in mice. Pharmacol. Biochem. Behav. 2000;67:489–495. [PubMed] [Google Scholar]

135. Raber J. Detrimental effects of chronic hypothalamic-pituitary-adrenal axis activation. From obesity to memory deficits. Mol. Neurobiol. 1998;18:1–22. [PubMed] [Google Scholar]

136. Shepherd J. K., Grewal S. S., Fletcher A., Bill D. J., Dourish C. T. Behavioural and pharmacological characterisation of the elevated “zero-maze” as an animal model of anxiety. Psychopharmacology (Berlin) 1994;116:56–64. [PubMed] [Google Scholar]

137. Killcross S., Robbins T. W., Everitt B. J. Different types of fear-conditioned behaviour mediated by separate nuclei within amygdala. Nature (London) 1997;388:377–380. [PubMed] [Google Scholar]

138. Toyota H., Dugovic C., Koehl M., Laposky A. D., Weber C., Ngo K., Wu Y., Lee D. H., Yanai K., Sakurai E., et al. Behavioral characterization of mice lacking histamine H3 receptors. Mol. Pharmacol. 2002;62:389–397. [PubMed] [Google Scholar]

139. Takahashi K., Suwa H., Ishikawa T., Kotani H. Targeted disruption of H3 receptors results in changes in brain histamine tone leading to an obese phenotype. J. Clin. Invest. 2002;110:1791–1799. [PMC free article] [PubMed] [Google Scholar]

140. DeVries G. J., Buijs R. M., Van Leeuwen F. W., Caffe A. R., Swaab D. F. The vasopressinergic innervation of the brain in normal and castrated rats. J. Comp. Neurol. 1985;233:236–254. [PubMed] [Google Scholar]

141. Treit D., Menard J. Dissociations among the anxiolytic effects of septal, hippocampal, and amygdaloid lesions. Behav. Neurosci. 1997;111:653–658. [PubMed] [Google Scholar]

142. Kesner R. P., Bolland B. L., Dakis M. Memory for spatial locations, motor responses, and objects: triple dissociation among the hippocampus, caudate nucleus, and extrastriate visual cortex. Exp. Brain Res. 1993;93:462–470. [PubMed] [Google Scholar]

143. Ennaceur A., Aggleton J. P. The effects of neurotoxic lesions of the perirhinal cortex combined to fornix transection on object recognition memory in the rat. Behav. Brain Res. 1997;88:181–193. [PubMed] [Google Scholar]

144. Bongers G., Leurs R., Robertson J., Raber J. Role of H3-receptor-mediated signaling in anxiety and cognition in wild-type and Apoe−/− mice. Neuropsychopharmacology. 2004;29:441–449. [PubMed] [Google Scholar]

145. Morris R. Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods. 1984;11:47–60. [PubMed] [Google Scholar]

146. Bach M. E., Hawkins R. D., Osman M., Kandel E. R., Mayford M. Impairment of spatial but not contextual memory in CaMKII mutant mice with a selective loss of hippocampal LTP in the range of the theta frequency. Cell. 1995;81:905–915. [PubMed] [Google Scholar]

147. Barnes C. A., Jung M. W., McNaughton B. L., Korol D. L., Andreasson K., Worley P. F. LTP saturation and spatial learning disruption: effects of task variables and saturation levels. J. Neurosci. 1994;14:5793–5806. [PMC free article] [PubMed] [Google Scholar]

148. Rizk A., Curley J., Robertson J., Raber J. Anxiety and cognition in histamine H3 receptor−/− mice. Eur. J. Neurosci. 2004;19:1992–1996. [PubMed] [Google Scholar]

149. Hall M. E., Mayer M. A. Effects of alpha methyl-para-tyrosine on the recall of a passive avoidance response. Pharmacol. Biochem. Behav. 1975;3:579–582. [PubMed] [Google Scholar]

150. Yanai K., Son L. Z., Endou M., Sakurai E., Watanabe T. Targeting disruption of histamine H1 receptors in mice: behavioral and neurochemical characterization. Life Sci. 1998;62:1607–1610. [PubMed] [Google Scholar]

151. Fiore M., Carere C., Moroni R., Aloe L. Passive avoidance response in mice infected with Schistosoma mansoni. Physiol. Behav. 2002;75:449–454. [PubMed] [Google Scholar]

152. Jones B. J., Roberts D. J. A rotarod suitable for quantitative measurements of motor incoordination in naive mice. Naunyn Schmiedebergs Arch. Exp. Pathol. Pharmakol. 1968;259:211. [PubMed] [Google Scholar]

153. Carter R. J., Lione L. A., Humby T., Mangiarini L., Mahal A., Bates G. P., Dunnett S. B., Morton A. J. Characterization of progressive motor deficits in mice transgenic for the human Huntington's disease mutation. J. Neurosci. 1999;19:3248–3257. [PMC free article] [PubMed] [Google Scholar]

154. Rustay N. R., Wahlsten D., Crabbe J. C. Influence of task parameters on rotarod performance and sensitivity to ethanol in mice. Behav. Brain Res. 2003;141:237–249. [PubMed] [Google Scholar]

155. Jobst E. E., Enriori P. J., Cowley M. A. The electrophysiology of feeding circuits. Trends Endocrinol. Metab. 2004;15:488–499. [PubMed] [Google Scholar]

156. Speakman J. R. Obesity: the integrated roles of environment and genetics. J. Nutr. 2004;134:2090S–2105S. [PubMed] [Google Scholar]

157. Ahima R. S., Osei S. Y. Leptin signaling. Physiol. Behav. 2004;81:223–241. [PubMed] [Google Scholar]

158. Wilding J. P. Neuropeptides and appetite control. Diabet. Med. 2002;19:619–627. [PubMed] [Google Scholar]

159. Sainsbury A., Cooney G. J., Herzog H. Hypothalamic regulation of energy homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 2002;16:623–637. [PubMed] [Google Scholar]

160. Young L. J., Pitkow L. J., Ferguson J. N. Neuropeptides and social behavior: animal models relevant to autism. Mol. Psychiatry. 2002;7(suppl. 2):S38–S39. [PubMed] [Google Scholar]

161. Sluyter F., Arseneault L., Moffitt T. E., Veenema A. H., de Boer S., Koolhaas J. M. Toward an animal model for antisocial behavior: parallels between mice and humans. Behav. Genet. 2003;33:563–574. [PubMed] [Google Scholar]

162. Bielsky I. F., Young L. J. Oxytocin, vasopressin, and social recognition in mammals. Peptides. 2004;25:1565–1574. [PubMed] [Google Scholar]

163. Haxby J. V., Hoffman E. A., Gobbini M. I. Human neural systems for face recognition and social communication. Biol. Psychiatry. 2002;51:59–67. [PubMed] [Google Scholar]

164. Insel T. R., Winslow J. T., Wang Z., Young L. J. Oxytocin, vasopressin, and the neuroendocrine basis of pair bond formation. Adv. Exp. Med. Biol. 1998;449:215–224. [PubMed] [Google Scholar]

165. Winslow J. T., Insel T. R. Neuroendocrine basis of social recognition. Curr. Opin. Neurobiol. 2004;14:248–253. [PubMed] [Google Scholar]

166. Hatton G. I., Li Z. Mechanisms of neuroendocrine cell excitability. Adv. Exp. Med. Biol. 1998;449:79–95. [PubMed] [Google Scholar]

167. Ferguson J. N., Young L. J., Hearn E. F., Matzuk M. M., Insel T. R., Winslow J. T. Social amnesia in mice lacking the oxytocin gene. Nat. Genet. 2000;25:284–288. [PubMed] [Google Scholar]

168. Ostermeyer M. C., Elwood R. W. Pup recognition in Mus musculus: parental discrimination between their own and alien young. Dev. Psychobiol. 1983;16:75–82. [PubMed] [Google Scholar]

169. Miczek K. A., Maxson S. C., Fish E. W., Faccidomo S. Aggressive behavioral phenotypes in mice. Behav. Brain Res. 2001;125:167–181. [PubMed] [Google Scholar]

170. Miczek K. A. Aggressive and social stress responses in genetically modified mice: from horizontal to vertical strategy. Psychopharmacology (Berlin) 1999;147:17–19. [PubMed] [Google Scholar]

171. D'Souza U. M., Kel A., Sluyter F. From transcriptional regulation to aggressive behavior. Behav. Genet. 2003;33:549–562. [PubMed] [Google Scholar]

172. Karl T., Lin S., Schwarzer C., Sainsbury A., Couzens M., Wittmann W., Boey D., von Horsten S., Herzog H. Y1 receptors regulate aggressive behavior by modulating serotonin pathways. Proc. Natl. Acad. Sci. U.S.A. 2004;101:12742–12747. [PMC free article] [PubMed] [Google Scholar]

173. Murphy D. L., Andrews A. M., Wichems C. H., Li Q., Tohda M., Greenberg B. Brain serotonin neurotransmission: an overview and update with an emphasis on serotonin subsystem heterogeneity, multiple receptors, interactions with other neurotransmitter systems, and consequent implications for understanding the actions of serotonergic drugs. J. Clin. Psychiatry. 1998;59(suppl. 15):4–12. [PubMed] [Google Scholar]

174. Lesch K. P., Merschdorf U. Impulsivity, aggression, and serotonin: a molecular psychobiological perspective. Behav. Sci. Law. 2000;18:581–604. [PubMed] [Google Scholar]

175. White S. M., Kucharik R. F., Moyer J. A. Effects of serotonergic agents on isolation-induced aggression. Pharmacol. Biochem. Behav. 1991;39:729–736. [PubMed] [Google Scholar]

176. Malick J. B. The pharmacology of isolation-induced aggressive behavior in mice. Curr. Dev. Psychopharmacol. 1979;5:1–27. [PubMed] [Google Scholar]

177. Olivier B., Mos J. Rodent models of aggressive behavior and serotonergic drugs. Prog. Neuropsychopharmacol. Biol. Psychiatry. 1992;16:847–870. [PubMed] [Google Scholar]

178. Winslow J. T., Miczek K. A. Habituation of aggression in mice: pharmacological evidence of catecholaminergic and serotonergic mediation. Psychopharmacology (Berlin) 1983;81:286–291. [PubMed] [Google Scholar]

179. Yanai K., Son L. Z., Endou M., Sakurai E., Nakagawasai O., Tadano T., Kisara K., Inoue I., Watanabe T. Behavioural characterization and amounts of brain monoamines and their metabolites in mice lacking histamine H1 receptors. Neuroscience. 1998;87:479–487. [PubMed] [Google Scholar]

180. Krakowski M. Violence and serotonin: influence of impulse control, affect regulation, and social functioning. J Neuropsychiatry Clin. Neurosci. 2003;15:294–305. [PubMed] [Google Scholar]

181. Son L. Z., Yanai K., Mobarakeh J. I., Kuramasu A., Li Z. Y., Sakurai E., Hashimoto Y., Watanabe T. Histamine H1 receptor-mediated inhibition of potassium-evoked release of 5-hydroxytryptamine from mouse forebrains. Behav. Brain Res. 2001;124:113–120. [PubMed] [Google Scholar]

182. Raghavendra V., Kaur G., Kulkarni S. K. Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur. Neuropsychopharmacol. 2000;10:473–481. [PubMed] [Google Scholar]

183. Zomkowski A. D., Hammes L., Lin J., Calixto J. B., Santos A. R., Rodrigues A. L. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport. 2002;13:387–391. [PubMed] [Google Scholar]

184. Liu X., Peprah D., Gershenfeld H. K. Tail-suspension induced hyperthermia: a new measure of stress reactivity. J. Psychiatr. Res. 2003;37:249–259. [PubMed] [Google Scholar]

185. Rubio S., Begega A., Santin L. J., Arias J. L. Improvement of spatial memory by R-alpha-methylhistamine, a histamine H3-receptor agonist, on the Morris water-maze in rat. Behav. Brain Res. 2002;129:77–82. [PubMed] [Google Scholar]

186. Prast H., Argyriou A., Philippu A. Histaminergic neurons facilitate social memory in rats. Brain Res. 1996;734:316–318. [PubMed] [Google Scholar]

187. Miyazaki S., Imaizumi M., Onodera K. Effects of thioperamide, a histamine H3-receptor antagonist, on a scopolamine-induced learning deficit using an elevated plus-maze test in mice. Life Sci. 1995;57:2137–2144. [PubMed] [Google Scholar]

188. Miyazaki S., Onodera K., Imaizumi M., Timmerman H. Effects of clobenpropit (VUF-9153), a histamine H3-receptor antagonist, on learning and memory, and on cholinergic and monoaminergic systems in mice. Life Sci. 1997;61:355–361. [PubMed] [Google Scholar]

189. Blandina P. B. M., Giovannini M. G., Mannaoioni P. F. H3 receptor modulation of the release of neurotransmitters in vivo. In: Leurs R., Timmerman H., editors. The Histamine H3 Receptor. Amsterdam: Elsevier; 1998. pp. 27–40. [Google Scholar]

190. Gulat-Marnay C., Lafitte A., Arrang J. M., Schwartz J. C. Regulation of histamine release and synthesis in the brain by muscarinic receptors. J. Neurochem. 1989;52:248–254. [PubMed] [Google Scholar]

191. Giovannini M. G., Bartolini L., Bacciottini L., Greco L., Blandina P. Effects of histamine H3 receptor agonists and antagonists on cognitive performance and scopolamine-induced amnesia. Behav. Brain Res. 1999;104:147–155. [PubMed] [Google Scholar]

192. Molinengo L., Di Carlo G., Ghi P. Combined action of thioperamide plus scopolamine, diphenhydramine, or methysergide on memory in mice. Pharmacol. Biochem. Behav. 1999;63:221–227. [PubMed] [Google Scholar]

193. Ghi P., Orsetti M., Gamalero S. R., Ferretti C. Sex differences in memory performance in the object recognition test. Possible role of histamine receptors. Pharmacol. Biochem. Behav. 1999;64:761–766. [PubMed] [Google Scholar]

194. Smith C. P., Hunter A. J., Bennett G. W. Effects of R-alpha-methylhistamine and scopolamine on spatial learning in the rat assessed using a water maze. Psychopharmacology (Berlin) 1994;114:651–656. [PubMed] [Google Scholar]

195. Nakamura S., Takemura M., Ohnishi K., Suenaga T., Nishimura M., Akiguchi I., Kimura J., Kimura T. Loss of large neurons and occurrence of neurofibrillary tangles in the tuberomammillary nucleus of patients with Alzheimer's disease. Neurosci. Lett. 1993;151:196–199. [PubMed] [Google Scholar]

196. Bongers G., LeFevour A., Robertson J., Raber J. Role of H3 receptor-mediated signaling in cognition. Inflamm. Res. 2004;53(suppl. 1):S51–S52. [PubMed] [Google Scholar]

Page 2

Example of a behavioral test battery to determine developmental milestones